The treatment for septic arthritis requires an adequate drainage of purulent joint fluid and appropriate antimicrobial therapy.
Empiric therapy should be started after the collection joint fluid and blood sample, and these should be send for culture.
Empiric Therapy Adapted from
▸ Click on the following categories to expand treatment regimens.
▸ Children (3 mo - 14 yr)
|
Infants (1- 3 months)
|
High suspicion of MRSA
|
▸ Vancomycin 40 mg/kg/day q6-8h
|
Low suspicion of MRSA
|
▸ Nafcillin 37 mg/kg q6h (max 8-12 g/day) OR ▸ Oxacillin 37 mg/kg q6h (max 8-12 g/day) OR ▸ Clindamycin 7.5 mg/kg q6h
|
|
Children (3 mo - 14 yr)
|
Preferred Regimen
|
▸ Vancomycin 40 mg/kg/day IV q6-8h
|
PLUS
|
▸ Cephalosporin 3gen
|
|
Polyarticular
|
Preferred Regimen
|
▸ Ceftriaxone 1 gm IV q24h
|
|
|
CSF Gram Stain-Based Therapy Adapted from
▸ Click on the following categories to expand treatment regimens.
|
Gram-Positive Cocci
|
Preferred Regimen
|
▸ Vancomycin 15-20 mg/kg IV q8—12h (trough 15—20 μg/mL)
|
Alternative Regimen (For patients allergic to vancomycin)
|
▸ Linezolid OR ▸ Daptomycin
|
|
Gram-Negative Cocci
|
Preferred Regimen
|
▸ Ceftriaxone 1 g IV q24h
|
|
Pathogen-Based Therapy — Bacteria Adapted from
▸ Click on the following categories to expand treatment regimens.
▸ Staphylococcus epidermidis
▸ Methicillin-resistant S. aureus
▸ Streptococcus groups A, B, C, G
|
Staphylococcus aureus
|
Preferred Regimen
|
▸ Nafcillin 1.5-2 g IV q4h OR ▸ Oxacillin 1.5-2 g IV q4h OR
▸ Cefazolin 1 g IV q8h
|
Alternative Regimen
|
▸ Vancomycin 15 mg/kg IV q12h (do not exceed 2g/day)
|
|
Staphylococcus epidermidis
|
Preferred Regimen
|
▸ Vancomycin 15 mg/kg IV q12h
|
Alternative Regimen
|
▸ TMP-SMX OR
|
|
Methicillin-resistant S. aureus
|
Preferred Regimen
|
▸ Vancomycin 15 mg/kg IV q12h
|
Alternative Regimen
|
▸ Linezolid 600 mg IV/PO q12h
|
|
Streptococcus groups A, B, C, G
|
Preferred Regimen
|
▸ Penicillin G 20 MU IV q24h or divided in 6 doses/day OR ▸ Ceftriaxone 2 g IV or IM q24h OR ▸ Cefazolin 1 g IV q8h
|
Alternative Regimen
|
▸ Vancomycin 15mg/kg IV q12h
|
|
Neisseria gonorrhoeae
|
Preferred Regimen
|
▸ Ceftrixone 1 g IV q24h for 1-2 days after clinical improvement'
|
FOLLOWED BY
|
▸ Cefixime 400 mg po q12h for 1 week OR ▸ Ciprofloxacin 500 mg po q12h for 1 week OR ▸ Ofloxacin 400 mg PO q12h for 1 week
|
Alternative Regimen
|
▸ Ciprofloxacin 400 mg IV q12h for 1-2 days after clinical improvement OR ▸ Ofloxacin 400 mg iv q12h for 1-2 days after clinical improvement OR ▸ Spectinomycin 2 g IM q12h for 1-2 days after clinical improvement
|
FOLLOWED BY
|
▸ Ciprofloxacin 500 mg po q12h for 1 week' OR ▸ Ofloxacin 400 mg po q12h for 1 week
|
|
|
Pathogen-Based Therapy — Fungi
▸ Click on the following categories to expand treatment regimens.
|
Candida
|
Preferred Regimen
|
▸ Amphotericin B deoxycholate 0.5-1 mg/kg/day for 2-3 weeks
|
FOLLOWED BY
|
▸ Fluconazole to complete a total duration of therapy of 6-12 months.
|
|
|
Preferred Regimen
|
▸ Itraconazole 400 mg/day for at least 12 months
|
|
|
Pathogen-Based Therapy in Patients with Prosthetic Joint — Bacteria Adapted from Diagnosis and Management of Prosthetic Joint Infection CID 2013:56[1]
▸ Click on the following categories to expand treatment regimens.
▸ Staphylococci, oxacillin-susceptible
▸ Staphylococci, oxacillin-resistant
▸ Enterococcus spp, penicillin-susceptible
▸ Enterococcus spp, penicillin-resistant
|
Staphylococci, oxacillin-resistant
|
Preferred Regimen
|
▸ Vancomycin 15 mg/kg IV q12h
|
Alternative Regimen
|
▸ Daptomycin 6 mg/kg IV q24h OR ▸ Linezolid 600 mg PO/IV q12h
|
|
Enterococcus spp, penicillin-susceptible
|
Preferred Regimen
|
▸ Penicillin G 20-40 MU IV q24h continuously or divided in 6 doses
|
Alternative Regimen
|
▸ Vancomycin IV 15 mg/kg q12h OR ▸ Daptomycin 6 mg/kg IV q24h OR ▸ Linezolid 600 mg PO/IV q12h
|
|
Enterococcus spp, penicillin-resistant
|
Preferred Regimen
|
▸ Vancomycin IV 15 mg/kg q12h
|
Alternative Regimen
|
▸ Daptomycin 6 mg/kg IV q24h OR ▸ Linezolid 600 mg PO/IV q12h
|
|
Staphylococcus aureus, Methicillin sensitive
|
Preferred Regimen
|
▸ Nafcillin 1.5—2 g IV q4h OR ▸ Oxacillin 1.5—2 g IV q4h
|
Alternative Regimen
|
▸ Vancomycin 15 mg/kg IV q6h (trough 15—20 μg/mL) OR ▸ Linezolid 600 mg IV q12h OR ▸ Daptomycin 6 mg/kg IV q24h
|
|
|
CSF Gram Stain-Based Therapy Adapted from
▸ Click on the following categories to expand treatment regimens.
|
Gram-Positive Cocci
|
Preferred Regimen
|
▸ Vancomycin 15-20 mg/kg IV q8—12h (trough 15—20 μg/mL)
|
Alternative Regimen (For patients allergic to vancomycin)
|
▸ Linezolid OR ▸ Daptomycin
|
|
Gram-Negative Cocci
|
Preferred Regimen
|
▸ Ceftriaxone 1 g IV q24h
|
|
|
|
- ↑ Osmon, D. R.; Berbari, E. F.; Berendt, A. R.; Lew, D.; Zimmerli, W.; Steckelberg, J. M.; Rao, N.; Hanssen, A.; Wilson, W. R. (2012). "Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases. 56 (1): e1–e25. doi:10.1093/cid/cis803. ISSN 1058-4838.